Boothbay Fund Management LLC Sells 6,590 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Boothbay Fund Management LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 92.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 533 shares of the medical equipment provider's stock after selling 6,590 shares during the period. Boothbay Fund Management LLC's holdings in Intuitive Surgical were worth $278,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical during the fourth quarter worth $28,000. Finally, Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ISRG shares. Piper Sandler dropped their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price on the stock. Finally, Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $1.36 on Tuesday, reaching $530.46. The stock had a trading volume of 1,125,053 shares, compared to its average volume of 1,622,438. The stock has a market cap of $190.13 billion, a P/E ratio of 82.76, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a fifty-two week low of $379.67 and a fifty-two week high of $616.00. The business's 50-day moving average price is $503.33 and its two-hundred day moving average price is $534.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the business posted $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This trade represents a 27.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock valued at $17,229,143 over the last three months. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.